First-in-class anti-CD96 monoclonal antibody alone or with dostarlimab for advanced tumors

2024/05/0117:42:19 science 1014
First-in-class anti-CD96 monoclonal antibody alone or with dostarlimab for advanced tumors - DayDayNews First-in-class anti-CD96 monoclonal antibody alone or with dostarlimab for advanced tumors - DayDayNews
2:01
* All content videos are shared, reposted and embedded from YouTube. If there is any violation or error, please contact us to delete it.

Recommended

science Latest News

Site Latest News